BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 28384630)

  • 1. Esophageal Cancer: New Insights into a Heterogenous Disease.
    Krug S; Michl P
    Digestion; 2017; 95(4):253-261. PubMed ID: 28384630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant (postoperative) therapy for esophageal cancer.
    Ku GY; Ilson DH
    Thorac Surg Clin; 2013 Nov; 23(4):525-33. PubMed ID: 24199702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT
    Tang H; Tan L; Shen Y; Wang H; Lin M; Feng M; Xu S; Guo W; Qian C; Liu T; Zeng Z; Hou Y; Yu Z; Jiang H; Li Z; Chen C; Lian C; Du M; Li H; Xie D; Yin J; Zhao N; Wang Q
    BMC Cancer; 2017 Jun; 17(1):450. PubMed ID: 28659128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286).
    Hoeppner J; Lordick F; Brunner T; Glatz T; Bronsert P; Röthling N; Schmoor C; Lorenz D; Ell C; Hopt UT; Siewert JR
    BMC Cancer; 2016 Jul; 16():503. PubMed ID: 27435280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy in the multimodality management of esophageal cancer.
    Encheva E; Kolev N; Tonev A; Ignatov V; Shterev S; Petrov D; Zlatarov A; Koleva I; Chaushev B; Kirilova T; Ivanov K
    Khirurgiia (Sofiia); 2014; (3):12-9. PubMed ID: 25799618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perioperative management of esophageal cancer.
    Okines A; Sharma B; Cunningham D
    Nat Rev Clin Oncol; 2010 Apr; 7(4):231-8. PubMed ID: 20212503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant Treatment for Locally Invasive Esophageal Cancer.
    Iams WT; Villaflor VM
    World J Surg; 2017 Jul; 41(7):1719-1725. PubMed ID: 28271259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controversies in the treatment of local and locally advanced gastric and esophageal cancers.
    Cohen DJ; Leichman L
    J Clin Oncol; 2015 Jun; 33(16):1754-9. PubMed ID: 25918302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
    Burt BM; Groth SS; Sada YH; Farjah F; Cornwell L; Sugarbaker DJ; Massarweh NN
    Ann Surg; 2017 Aug; 266(2):297-304. PubMed ID: 27501170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival outcomes of resected patients who demonstrate a pathologic complete response after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer.
    Hammoud ZT; Kesler KA; Ferguson MK; Battafarrano RJ; Bhogaraju A; Hanna N; Govindan R; Mauer AA; Yu M; Einhorn LH
    Dis Esophagus; 2006; 19(2):69-72. PubMed ID: 16643172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant Therapies for Esophageal Cancer.
    Abdelhakeem A; Blum Murphy M
    Thorac Surg Clin; 2022 Nov; 32(4):457-465. PubMed ID: 36266033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Esophageal cancer subtypes and survival rates at the VA Caribbean Healthcare System: a 10-year experience.
    González Ortiz DI; Toro DH
    Bol Asoc Med P R; 2009; 101(3):14-7. PubMed ID: 20120980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant and adjuvant therapy in esophageal cancer.
    Weiss JA; Jain S
    J Gastrointest Oncol; 2023 Aug; 14(4):1927-1932. PubMed ID: 37720447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.
    Ajani JA; D'Amico TA; Bentrem DJ; Chao J; Corvera C; Das P; Denlinger CS; Enzinger PC; Fanta P; Farjah F; Gerdes H; Gibson M; Glasgow RE; Hayman JA; Hochwald S; Hofstetter WL; Ilson DH; Jaroszewski D; Johung KL; Keswani RN; Kleinberg LR; Leong S; Ly QP; Matkowskyj KA; McNamara M; Mulcahy MF; Paluri RK; Park H; Perry KA; Pimiento J; Poultsides GA; Roses R; Strong VE; Wiesner G; Willett CG; Wright CD; McMillian NR; Pluchino LA
    J Natl Compr Canc Netw; 2019 Jul; 17(7):855-883. PubMed ID: 31319389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and pathogenesis of esophageal cancer: management and its controversial results (review).
    Stathopoulos GP; Tsiaras N
    Oncol Rep; 2003; 10(2):449-54. PubMed ID: 12579288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative and adjuvant therapies for upper gastrointestinal cancers.
    Varadhachary G; Ajani JA
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current diagnosis and therapy of esophageal carcinoma].
    Mühr-Wilkenshoff F; Stahl M; Faiss S; Zeitz M; Scherübl H
    Z Gastroenterol; 2004 Jul; 42(7):615-21. PubMed ID: 15248111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of locoregional stage esophageal cancer: a single center experience.
    Javle MM; Nwogu CE; Donohue KA; Iyer RV; Brady WE; Khemka SV; Smith JL; Demmy TL; Yang GY; Nava HR
    Dis Esophagus; 2006; 19(2):78-83. PubMed ID: 16643174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Modality Therapy for Management of Esophageal Cancer: Current Approach Based on Experiences from East and West.
    Moaven O; Wang TN
    Surg Clin North Am; 2019 Jun; 99(3):479-499. PubMed ID: 31047037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New therapeutic strategies for squamous cell cancer and adenocarcinoma.
    Wijnhoven BPL; Toxopeus ELA; Vallböhmer D; Knoefel WT; Krasna MJ; Perez K; van Rossum PSN; Ruurda JP; van Hillegersberg R; Schiesser M; Schneider P; Felix VN
    Ann N Y Acad Sci; 2013 Oct; 1300():213-225. PubMed ID: 24117644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.